Pronađeno: 1-8 / 8 radova

Autori: Jassem Jacek

>> Filter: Samo Article i Review

>> Sve godine

Naslov Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC (Article)
Autori Jassem Jacek ... Andric Zoran G  ... (broj koautora 19) 
Info JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 11, str. 1872-1882
Projekat Roche HoldingGenentech; F. Hoffmann-La Roche Ltd.Hoffmann-La Roche; Genentech, Inc.Roche HoldingGenentech
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis (Article)
Autori Cufer Tanja Ciuleanu Tudor E Berzinec Peter Galffy Gabriela Jakopovic Marko Jassem Jacek Jovanovic Dragana D Mihaylova Zhasmina Ostoros Gyula Thallinger Christiane Zemanova Milada Zielinski Christoph 
Info ONCOLOGIST, (2020), vol. 25 br. 3, str. E598-E601
Projekat AstraZeneca
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Delays in diagnosis and treatment of breast cancer: a multinational analysis (Article)
Autori Jassem Jacek Ozmen Vahit Bacanu Florin Drobniene Monika Eglitis Janis Lakshmaiah Kuntegowdanahalli C Kahan Zsuzsanna Mardiak Jozef Pienkowski Tadeusz Semiglazova Tatiana Stamatovic Ljiljana Timcheva Constanta Vasovic Suzana Vrbanec Damir Zaborek Piotr 
Info EUROPEAN JOURNAL OF PUBLIC HEALTH, (2014), vol. 24 br. 5, str. 761-767
Projekat Roche Poland
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey (Meeting Abstract)
Autori Jassem Jacek Bacanu Florin Eglitis Janis Mardiak Jozef Pienkowski Tadeusz Kahan Zsuzsanna Ozmen Vahit Drobniene Monika Vrbanec Damir Semiglazova Tatyana Stamatovic Ljiljana Timcheva Constanta Vasovic Suzana Zaborek Piotr 
Info JOURNAL OF CLINICAL ONCOLOGY, (2012), vol. 30 br. 15, Suppl. S, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey (Meeting Abstract)
Autori Jassem Jacek Ozmen Vahit Bacanu Florin Drobniene Monika Eglitis Janis Kahan Zsuzsanna Lakshmaiah Kuntegowdanahalli C Mardiak Jozef Pienkowski Tadeusz Semiglazova Tatiana Stamatovic Ljiljana Timcheva Constanta Vasovic Suzana Vrbanec Damir Zaborek Piotr 
Info CANCER RESEARCH, (2012), vol. 72 br. , Suppl. 24, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial (Article)
Autori Jassem Jacek Pienkowski Tadeusz Pluzanska Anna Jelic Svetislav S Gorbunova Vera Berzins Juris Nagykalnai Thomas Biganzoli Laura Aloe Alessandra Astier Ludovic Munier Stephane 
Info ONKOLOGIE, (2009), vol. 32 br. 8-9, str. 468-472
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov A randomized phase III multicenter trial of doxorubicin and paclitaxel (AT) versus fluorouracil-doxorubicin-cyclophosphamide (FAC) as first-line therapy metastatic breast cancer (MBC): long-term efficacy and external review of results. (Meeting Abstract)
Autori Jassem Jacek Pluzanska Anna Pienkowski Tadeusz Gershanovitch MA Uziely B Jelic Svetislav S Biganzoli Laura Gwyther SJ Aloe Alessandra Astier Ludovic Munier Stephane 
Info BREAST CANCER RESEARCH AND TREATMENT, (2004), vol. 88 br. , Suppl. Suppl. 1, str. S198-S198
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial (Article)
Autori Jassem Jacek Pienkowski Tadeusz Pluzanska Anna Jelic Svetislav B Gorbunova Vera Mrsic-Krmpotic Zrinka Berzins Juris Nagykalnai Thomas Wigler N Renard J Munier Stephane Weil C 
Info JOURNAL OF CLINICAL ONCOLOGY, (2001), vol. 19 br. 6, str. 1707-1715
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX